Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stemline TherapeuticsLannettMinerva NeurosciencesINDIVIOR PLC/SCorbus Pharmaceuticals
SymbolNASDAQ:STMLNYSE:LCINASDAQ:NERVOTCMKTS:INVVYNASDAQ:CRBP
Price Information
Current Price$4.76$7.29$5.70$2.72$5.19
52 Week RangeBuyHoldBuyN/ABuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/ABuy
Consensus Price Target$15.13$14.00$20.25N/A$53.00
% Upside from Price Target217.75% upside92.04% upside255.26% upsideN/A921.19% upside
Trade Information
Market Cap$224.67 million$284.80 million$208.26 million$397.46 million$354.48 million
Beta1.441.731.46-0.31.38
Average Volume968,398801,768369,24117,9981,032,761
Sales & Book Value
Annual Revenue$43.22 million$655.41 millionN/A$785 million$36.14 million
Price / Sales5.550.45N/A0.5110.41
CashflowN/A$3.88 per shareN/A$1.40 per shareN/A
Price / CashN/A1.88N/A1.94N/A
Book Value$3.26 per share$8.49 per share$0.71 per share$1.43 per share$0.10 per share
Price / Book1.460.86N/A1.9051.90
Profitability
Net Income$-76,820,000.00$-272,110,000.00$-72,180,000.00$134 million$-71,450,000.00
EPS($1.83)$2.35($1.85)$1.15($1.12)
Trailing P/E RatioN/AN/AN/A3.20N/A
Forward P/E RatioN/A5.10N/A7.99N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-177.74%-0.70%N/A17.07%-197.69%
Return on Equity (ROE)-56.00%18.75%-126.64%88.11%-227.79%
Return on Assets (ROA)-47.31%5.17%-65.86%10.97%-94.39%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A1.88%N/A1.36%1.31%
Current Ratio8.00%1.95%7.11%1.83%1.09%
Quick Ratio7.95%1.29%7.11%1.73%1.09%
Ownership Information
Institutional Ownership Percentage81.86%98.93%82.60%N/A47.68%
Insider Ownership Percentage13.10%12.86%12.00%N/A8.20%
Miscellaneous
Employees921,0201391577
Shares Outstanding50.38 million40.34 million39.22 million146.34 million72.49 million
Next Earnings Date5/8/2020 (Estimated)5/4/2020 (Estimated)5/4/2020 (Estimated)5/7/2020 (Estimated)5/14/2020 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel